Literature DB >> 109357

Distribution of HLA histocompatibility antigens, ABO blood groups and Rh antigens in alcoholic liver disease.

M Meléndez, L Vargas-Tank, C Fuentes, R Armas-Merino, D Castillo, C Wolff, M E Wegmann, J Soto.   

Abstract

The distribution of 16 antigens of the HLA-A and 15 antigens of the HLA-B series of HLA system, the blood groups ABO, and Rh antigens were studied in 40 alcoholics with cirrhosis, 18 alcoholics without cirrhosis, and in normal control subjects. The group of alcoholics with cirrhosis showed a significantly high frequency of HLA-B13 (corrected P less than 0.01) when compared with normal subjects, while the frequency of HLA-B13 was similar to normal in alcoholics without cirrhosis. On the basis of these findings, its seems that the carriers of HLA-B13 are more susceptible to liver damage caused by alcohol. Both groups of alcoholics and the normal controls had a similar distribution of ABO blood groups and Rh antigens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109357      PMCID: PMC1412391          DOI: 10.1136/gut.20.4.288

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Observations on blood group distribution in peptic ulcer and gastric cancer.

Authors:  R DOLL; B F SWYNNERTON; A C NEWELL
Journal:  Gut       Date:  1960-03       Impact factor: 23.059

Review 3.  The association between genes in the major histocompatibility complex and disease susceptibility,.

Authors:  T Sasazuki; H O McDevitt; F C Grumet
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

4.  The histocompatibility system and human disease.

Authors:  J G Schaller; G S Omenn
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

5.  Histocompatibility antigens in chronic liver disease.

Authors:  B B Scott; S M Rajah; M S Losowsky
Journal:  Gastroenterology       Date:  1977-01       Impact factor: 22.682

Review 6.  HL-A antigens and disease. Statistical and genetical considerations.

Authors:  A Svejgaard; C Jersild; L S Nielsen; W F Bodmer
Journal:  Tissue Antigens       Date:  1974

7.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

8.  Relation of ABO blood-groups to atherosclerosis.

Authors:  K J Kingsbury
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

9.  [A clinico-pathological study of the liver damage in alcoholic patients].

Authors:  I Insunza; H Iturriaga; G Ugarte; H Altschiller
Journal:  Rev Med Chil       Date:  1969-12       Impact factor: 0.553

10.  Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease.

Authors:  R J Bailey; N Krasner; A L Eddleston; R Williams; D E Tee; D Doniach; L A Kennedy; J R Batchelor
Journal:  Br Med J       Date:  1976-09-25
View more
  5 in total

Review 1.  Genetic predisposition to alcoholic liver disease.

Authors:  C P Day; M F Bassendine
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

2.  Are HLA antigens important in the development of alcohol-induced liver disease?

Authors:  R Faizallah; J C Woodrow; N K Krasner; R J Walker; A I Morris
Journal:  Br Med J (Clin Res Ed)       Date:  1982-08-21

3.  HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease.

Authors:  M Y Morgan; M G Ross; C M Ng; D M Adams; H C Thomas; S Sherlock
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

4.  Histocompatibility antigens in patients with alcoholic liver disease in Scotland and northeastern England: failure to show an association.

Authors:  P R Mills; R N MacSween; H M Dick; W S Hislop
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

5.  The Probable Association between Blood Groups and Prognosis of COVID-19.

Authors:  Maryam Nasiri; Javad Khodadadi; Zahra Hajrezaei; Negar Bizhani
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.